Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/31/21 → 03/8/25 |
Funding
- Janssen Research and Development LLC: $20,952.00
Actelion: A Phase 3, Prospective, Multicenter, Double-blind, Double-Dummy, Randomized, Active-controlled, Parallel-group, Group-Sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75mg...
- Patel, Jignesh (PI)
- Strachan, Paul (PI)
Project: Research